These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 27862317)

  • 1. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
    Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications.
    Quader MA; Wolfe LG; Kasirajan V
    J Heart Lung Transplant; 2015 Jan; 34(1):75-81. PubMed ID: 25150620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation.
    Cheng A; Trivedi JR; Van Berkel VH; Massey HT; Slaughter MS
    J Card Surg; 2016 Oct; 31(10):648-653. PubMed ID: 27573150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
    Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
    JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of insurance type on listing status and wait-list mortality of patients with left ventricular assist devices as bridge to transplantation.
    Briasoulis A; Akintoye E; Inampudi C; Hammoud A; Alvarez P
    ESC Heart Fail; 2020 Jun; 7(3):804-810. PubMed ID: 32135039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices.
    Zafar F; Castleberry C; Khan MS; Mehta V; Bryant R; Lorts A; Wilmot I; Jefferies JL; Chin C; Morales DLS
    J Heart Lung Transplant; 2015 Jan; 34(1):82-88. PubMed ID: 25447574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.